黄素通过上调Nrf2的调节来逆转埃拉斯诱导的冠状细胞铁亡
Yizhao Zhou1, Zhen Jia1, Jing Wang1
1Department of Orthopedics, Hunan Provincial People's Hospital, The First-Affiliated Hospital of Hunan Normal University, Changsha, 410005, China.
Heliyon
|September 29, 2023
概括
黄素通过抑制体细胞中的铁亡来预防骨关节炎 (OA). 这种天然化合物激活Nrf2通路,为OA治疗提供了潜在的治疗策略.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨关节炎 (OA) 与铁亡有关,这是一种细胞死亡途径,涉及脂质过氧化.
- 来自黄的黄素具有抗氧化特性,但其在OA铁中所起的作用尚不清楚.
研究的目的:
- 为了研究黄素对红细胞的保护作用,防止埃拉斯诱导的铁亡.
- 阐明涉及Nrf2信号通路的潜在分子机制.
主要方法:
- 细胞活力测定 (CCK-8),生物化学分析 (LDH,SOD,MDA,ROS,Fe2+) 和蛋白质表达研究 (西斑,免疫光) 在细胞上进行.
- 通过siRNA进行Nrf2淘汰用于探索机制.
- 使用了OA的体内小鼠模型,进行了组织学和免疫组织化学分析.
主要成果:
- 埃拉斯诱导了状细胞铁,增加了LDH,MDA,ROS和Fe2+,同时降低了SOD,GSH-PX,SLC7A11,GPX4和FTH1.1.
- 库尔库逆转了埃拉斯诱导的铁亡标志物,并提高了Nrf2表达的调节.
- Nrf2 knockdown 废除了黄素在体外和体外的保护作用,抑制了OA的进展.
结论:
- 黄素通过激活Nrf2信号通路来抑制OA中的冠状细胞铁.
- 这些发现支持黄素作为治疗骨关节炎的治疗剂的潜力.
更多相关视频
相关概念视频
Role of ER in the Secretory Pathway
5.5K
Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.5K
The Unfolded Protein Response
4.7K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.7K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K


